A real-world safety evaluation of new oral anticoagulants in elderly patients: evidence from the Adverse Drug Reaction Monitoring Center of Henan Province
Attention should be paid to the clinical use of NOACs in elderly patients, and pharmacovigilance should be strengthened, and the implementation of individualised medication regimen should be used to promote clinical safety and rational drug use.
Authors
- Jie Chen (ORCID: https://orcid.org/0000-0002-9254-4413)
- Zhongyi Sun (ORCID: https://orcid.org/0000-0002-1285-2177)
- Jiajing Cao (ORCID: https://orcid.org/0009-0006-3432-9228)
- Xuedong Jia (ORCID: https://orcid.org/0000-0003-4317-5284)
- Ming Xia (ORCID: https://orcid.org/0000-0002-6552-3377)
- HU You-hong
- Yin Zhao (ORCID: https://orcid.org/0000-0001-7007-2999)
- Mingyang Sun (ORCID: https://orcid.org/0000-0003-3181-6793)
- Danfeng Ma (ORCID: https://orcid.org/0009-0005-7032-8313)
- Weigao Cheng
- Chen Chen (ORCID: https://orcid.org/0009-0006-6867-5102)
Institutions
- Centre for Drug Research and Development (CA)
- China Institute of Veterinary Drug Control (CN)
- Hanyang University Medical Center (KR)
- First Affiliated Hospital of Zhengzhou University (CN)
- Hanyang University (KR)
- Henan Normal University (CN)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1080/20523211.2025.2547678
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00